JP2017508454A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017508454A5 JP2017508454A5 JP2016552921A JP2016552921A JP2017508454A5 JP 2017508454 A5 JP2017508454 A5 JP 2017508454A5 JP 2016552921 A JP2016552921 A JP 2016552921A JP 2016552921 A JP2016552921 A JP 2016552921A JP 2017508454 A5 JP2017508454 A5 JP 2017508454A5
- Authority
- JP
- Japan
- Prior art keywords
- coli
- strain
- methods
- crm197
- reduced genome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims description 59
- 241000588724 Escherichia coli Species 0.000 claims description 44
- 108010071134 CRM197 (non-toxic variant of diphtheria toxin) Proteins 0.000 claims description 28
- 230000035772 mutation Effects 0.000 claims description 14
- 238000012217 deletion Methods 0.000 claims description 12
- 230000037430 deletion Effects 0.000 claims description 12
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 10
- 125000003729 nucleotide group Chemical group 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 108020004414 DNA Proteins 0.000 claims description 7
- 241001646716 Escherichia coli K-12 Species 0.000 claims description 7
- 230000037433 frameshift Effects 0.000 claims description 6
- 101150085542 relA gene Proteins 0.000 claims description 6
- 239000013604 expression vector Substances 0.000 claims description 5
- 231100000221 frame shift mutation induction Toxicity 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 238000005571 anion exchange chromatography Methods 0.000 claims description 4
- 210000004027 cell Anatomy 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 238000004191 hydrophobic interaction chromatography Methods 0.000 claims description 4
- 101150067967 iclR gene Proteins 0.000 claims description 4
- 101150020087 ilvG gene Proteins 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 4
- 230000004048 modification Effects 0.000 claims description 4
- 239000008363 phosphate buffer Substances 0.000 claims description 4
- 101150100149 rph gene Proteins 0.000 claims description 4
- 101710184601 Acetolactate synthase 2, chloroplastic Proteins 0.000 claims description 3
- 101100350387 Bacillus subtilis (strain 168) opuD gene Proteins 0.000 claims description 3
- 101100433002 Escherichia coli (strain K12) ytfQ gene Proteins 0.000 claims description 3
- 108700006385 OmpF Proteins 0.000 claims description 3
- 102000029785 Orotate phosphoribosyltransferase Human genes 0.000 claims description 3
- 108010055012 Orotidine-5'-phosphate decarboxylase Proteins 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 3
- 101150073640 ompF gene Proteins 0.000 claims description 3
- 210000001322 periplasm Anatomy 0.000 claims description 3
- 101150079601 recA gene Proteins 0.000 claims description 3
- 101100278439 Archaeoglobus fulgidus (strain ATCC 49558 / DSM 4304 / JCM 9628 / NBRC 100126 / VC-16) pol gene Proteins 0.000 claims description 2
- 108091026890 Coding region Proteins 0.000 claims description 2
- 239000007983 Tris buffer Substances 0.000 claims description 2
- 239000006227 byproduct Substances 0.000 claims description 2
- 229940041514 candida albicans extract Drugs 0.000 claims description 2
- 239000013592 cell lysate Substances 0.000 claims description 2
- 239000003599 detergent Substances 0.000 claims description 2
- 101150067506 dinB gene Proteins 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 238000003780 insertion Methods 0.000 claims description 2
- 230000037431 insertion Effects 0.000 claims description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 2
- 101150005648 polB gene Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 210000002966 serum Anatomy 0.000 claims description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 2
- 239000012138 yeast extract Substances 0.000 claims description 2
- 101100295756 Acinetobacter baumannii (strain ATCC 19606 / DSM 30007 / JCM 6841 / CCUG 19606 / CIP 70.34 / NBRC 109757 / NCIMB 12457 / NCTC 12156 / 81) omp38 gene Proteins 0.000 claims 2
- 101150042295 arfA gene Proteins 0.000 claims 2
- 238000012937 correction Methods 0.000 claims 2
- 101150087557 omcB gene Proteins 0.000 claims 2
- 101150115693 ompA gene Proteins 0.000 claims 2
- YMJUYKGULHVQPS-UHFFFAOYSA-N 2,4-dioxo-1h-pyrimidine-6-carboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)C1=CC(=O)NC(=O)N1 YMJUYKGULHVQPS-UHFFFAOYSA-N 0.000 claims 1
- 108010000700 Acetolactate synthase Proteins 0.000 claims 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
- 101150082462 arpA gene Proteins 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 210000000805 cytoplasm Anatomy 0.000 claims 1
- 230000002093 peripheral effect Effects 0.000 claims 1
- 238000012546 transfer Methods 0.000 claims 1
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 241000660147 Escherichia coli str. K-12 substr. MG1655 Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108010079246 OMPA outer membrane proteins Proteins 0.000 description 1
- 108700028353 OmpC Proteins 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461947234P | 2014-03-03 | 2014-03-03 | |
| US61/947,234 | 2014-03-03 | ||
| PCT/US2015/018338 WO2015134402A1 (en) | 2014-03-03 | 2015-03-02 | Enhanced production of recombinant crm197 in e. coli |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019011493A Division JP6636661B2 (ja) | 2014-03-03 | 2019-01-25 | 大腸菌における組換えｃｒｍ１９７の産生強化 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017508454A JP2017508454A (ja) | 2017-03-30 |
| JP2017508454A5 true JP2017508454A5 (enExample) | 2018-01-11 |
| JP6473460B2 JP6473460B2 (ja) | 2019-02-20 |
Family
ID=54055763
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016552921A Active JP6473460B2 (ja) | 2014-03-03 | 2015-03-02 | 大腸菌における組換えｃｒｍ１９７の産生強化 |
| JP2019011493A Active JP6636661B2 (ja) | 2014-03-03 | 2019-01-25 | 大腸菌における組換えｃｒｍ１９７の産生強化 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019011493A Active JP6636661B2 (ja) | 2014-03-03 | 2019-01-25 | 大腸菌における組換えｃｒｍ１９７の産生強化 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10479820B2 (enExample) |
| EP (1) | EP3113800B1 (enExample) |
| JP (2) | JP6473460B2 (enExample) |
| KR (1) | KR102315246B1 (enExample) |
| CN (1) | CN106456769B (enExample) |
| AU (2) | AU2015225439B2 (enExample) |
| CA (1) | CA2940316C (enExample) |
| WO (1) | WO2015134402A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6545676B2 (ja) * | 2013-11-14 | 2019-07-17 | スカラブ ゲノミクス， エルエルシー | 改善された代謝能力を有する細菌 |
| EP3221339B1 (en) | 2014-11-20 | 2024-08-21 | Biological E Limited | Codon optimized polynucleotide for high level expression of crm197 |
| AU2016242996B2 (en) * | 2015-04-02 | 2021-02-18 | Scarab Genomics, Llc | Materials and methods for extended continuous flow fermentation of reduced genome bacteria |
| KR101908590B1 (ko) * | 2017-02-01 | 2018-10-16 | (주)포바이오코리아 | Crm197의 용해성 단백질 발현 및 정제 방법 |
| ES2926535T3 (es) * | 2017-04-22 | 2022-10-26 | Biological E Ltd | Método mejorado para la producción de alto nivel de CRM |
| EP3444269A1 (en) | 2017-08-17 | 2019-02-20 | National Research Council of Canada | Systems and methods for the production of diphtheria toxin polypeptides |
| US20200331973A1 (en) * | 2017-09-01 | 2020-10-22 | Lorven Biologics Private Limited | Nucleic acid encoding crm197 and process for improved expression thereof |
| AU2018329671B2 (en) * | 2017-09-05 | 2023-12-07 | Scarab Genomics, Llc | Methods and compositions for improved expression of recombinant proteins |
| KR20200111685A (ko) * | 2018-01-19 | 2020-09-29 | 오비아이 파머 인코퍼레이티드 | Crm197 단백질 발현 |
| WO2019178587A1 (en) * | 2018-03-16 | 2019-09-19 | Bio-Rad Laboratories, Inc. | Purification of target molecules |
| KR102048456B1 (ko) | 2018-03-28 | 2019-11-25 | 강원대학교 산학협력단 | 재조합 대장균을 이용한 rCRM197 생산방법 |
| CN109402035A (zh) * | 2018-11-06 | 2019-03-01 | 华中农业大学 | 一种肠外致病性大肠杆菌重组菌株及其应用 |
| KR102099342B1 (ko) * | 2019-09-03 | 2020-04-10 | 주식회사 제노포커스 | Crm197 단백질 발현 방법 |
| NL2023863B1 (en) * | 2019-09-20 | 2021-05-25 | Univ Griffith | Protein particles and uses thereof |
| KR102142255B1 (ko) * | 2019-12-05 | 2020-08-07 | 주식회사 제노포커스 | Crm197 단백질 발현 방법 |
| BE1029145B1 (fr) | 2021-02-26 | 2022-09-27 | Curavac Europe | Methode de production d'une forme periplasmique de la proteine crm197 |
| BE1029146B1 (fr) * | 2021-02-26 | 2022-09-26 | Xpress Biologics | Procede de purification d'une proteine d'interet |
| CN119552230A (zh) * | 2024-12-12 | 2025-03-04 | 中国人民解放军军事科学院军事医学研究院 | 一种脂肪酸化修饰的白喉毒素抗原及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6989265B2 (en) * | 2002-01-23 | 2006-01-24 | Wisconsin Alumni Research Foundation | Bacteria with reduced genome |
| US7300776B2 (en) * | 2004-04-26 | 2007-11-27 | Ajinomoto Co., Inc. | L-amino acid-producing bacterium and a method for producing L-amino acid |
| US8178339B2 (en) * | 2005-08-20 | 2012-05-15 | Scarab Genomics Llc | Reduced genome E. coli |
| JP2009165355A (ja) * | 2006-04-28 | 2009-07-30 | Ajinomoto Co Inc | Ｌ−アミノ酸を生産する微生物及びｌ−アミノ酸の製造法 |
| JP5506149B2 (ja) * | 2007-11-22 | 2014-05-28 | 住友化学株式会社 | 昆虫由来のコリンアセチルトランスフェラーゼ活性に関わる有害生物の生理状態に変化を与える薬剤 |
| US8367380B2 (en) * | 2008-02-22 | 2013-02-05 | Scarab Genomics Llc | Compositions and methods for amino acid biosynthesis |
| DE102008063900A1 (de) * | 2008-12-19 | 2010-06-24 | Wacker Chemie Ag | Verfahren zur fermentativen Herstellung von heterologen Proteinen mittels Escherichia coli |
| IT1398927B1 (it) * | 2009-06-25 | 2013-03-28 | Consorzio Interuniversitario Per Lo Sviluppo Dei Sistemi A Grande Interfase Csgi | Espressione batterica di un gene artificiale per la produzione di crm197 e derivati. |
| GB0917647D0 (en) * | 2009-10-08 | 2009-11-25 | Glaxosmithkline Biolog Sa | Expression system |
| US8546125B2 (en) * | 2011-02-21 | 2013-10-01 | Tianjin Greenbio Material Co., Ltd. | Recombinant hosts and methods for manufacturing polyhydroxyalkanoate |
| WO2013059595A1 (en) * | 2011-10-20 | 2013-04-25 | Scarab Genomics, Llc | Reduced genome bacteria with improved genetic stability |
| US20160251609A1 (en) * | 2011-10-20 | 2016-09-01 | Scarab Genomics, Llc | Reduced Genome Bacteria With Improved Genetic Stability |
-
2015
- 2015-03-02 WO PCT/US2015/018338 patent/WO2015134402A1/en not_active Ceased
- 2015-03-02 CN CN201580011743.1A patent/CN106456769B/zh active Active
- 2015-03-02 US US15/122,891 patent/US10479820B2/en active Active
- 2015-03-02 JP JP2016552921A patent/JP6473460B2/ja active Active
- 2015-03-02 CA CA2940316A patent/CA2940316C/en active Active
- 2015-03-02 EP EP15758620.7A patent/EP3113800B1/en active Active
- 2015-03-02 KR KR1020167026716A patent/KR102315246B1/ko active Active
- 2015-03-02 AU AU2015225439A patent/AU2015225439B2/en active Active
-
2019
- 2019-01-25 JP JP2019011493A patent/JP6636661B2/ja active Active
-
2021
- 2021-03-17 AU AU2021201686A patent/AU2021201686A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017508454A5 (enExample) | ||
| JP6636661B2 (ja) | 大腸菌における組換えｃｒｍ１９７の産生強化 | |
| JP6545676B2 (ja) | 改善された代謝能力を有する細菌 | |
| WO2014121669A1 (zh) | 用改变乌头酸酶基因和/或其调控元件的细菌发酵生产l-赖氨酸的方法 | |
| EP3161125B1 (en) | Expression of polypeptides involved in lysine decarboxylation, and methods and applications thereof | |
| WO2019157823A1 (zh) | 丙谷二肽的制备方法、丙谷二肽制备用酶及应用 | |
| CN103146772B (zh) | 用乌头酸酶表达弱化和/或酶活性降低的细菌发酵生产l-赖氨酸的方法 | |
| CN103865944B (zh) | 一种生产核黄素的大肠杆菌菌株及构建方法及用途 | |
| Wang et al. | Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells | |
| TWI547558B (zh) | 生產ｌ－胺基酸的微生物和使用其的ｌ－胺基酸的生產方法 | |
| CN114854660B (zh) | 一种高产麦角硫因的基因工程菌 | |
| WO2022226493A1 (en) | Optimized methods for the production of psilocybin and intermediates or side products | |
| JP2010512168A (ja) | 組換えヒトアルギナーゼｉについての改善された発現系 | |
| CN115605602A (zh) | 用于生产肝素原的方法和具有肝素原生产能力的埃希氏杆菌属细菌 | |
| CN103131738B (zh) | 用改变乌头酸酶调控元件的细菌发酵生产l-赖氨酸的方法 | |
| EP0076037B1 (en) | Amplified expression of dna sequences | |
| WO2023286629A1 (ja) | 大腸菌を用いたプラスミドｄｎａの製造方法 | |
| TW201734199A (zh) | 具有提高的l-胺基酸生產力的微生物和使用其的l-胺基酸的生產方法 | |
| CN111100831A (zh) | 产左旋肉碱的重组菌及其构建方法与应用 | |
| CN103173505B (zh) | 用改变乌头酸酶调控元件的细菌发酵生产l-苏氨酸的方法 | |
| Wang et al. | Engineering for an HPV 9-valent Vaccine using Genomic Constitutive Over-expression and Low Lipopolysaccharide Levels in Escherichia Coli Cells | |
| CN103173504B (zh) | 用乌头酸酶表达弱化和/或酶活性降低的细菌发酵生产l-苏氨酸的方法 | |
| JP7764119B2 (ja) | Ｄｎａ断片、組み換えベクター、形質転換体及び窒素固定酵素 | |
| Subramanian et al. | Genome Sequence of the Yeast Strain Sporobolomyces phaffii RJAF-17, Which Produces the Lipoamino Acid Surfactants | |
| JP2022547010A (ja) | 大腸菌に基づく組換え株ならびにその構築方法および使用 |